Arkolith/Insider Trading/WHWK/Form 4

Dugan Margaret

Chief Medical OfficerWhitehawk Therapeutics, Inc. (WHWK) · full profile →Form 4 · filed Dec 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 1, 2025Grant(A)55K—$055K
Dec 1, 2025Grant(A)650K—$0650K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001909734-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML